Protein S is a
vitamin K-dependent
glycoprotein produced mainly in the liver with
anticoagulant, anti-inflammatory, immune-modulatory, and antiapoptotic properties.
Protein S exacerbates acute liver injury by prolonging the survival of liver immune cells. However, the effect of
protein S on chronic liver injury and
fibrosis is unknown. Here, we investigated whether human
protein S can affect chronic liver injury and
fibrosis. Liver injury/
fibrosis was induced by
carbon tetrachloride injection in mice overexpressing human
protein S and in wild-type mice. Human
protein S transgenic mice receiving
carbon tetrachloride showed significantly higher circulating levels of liver
transaminases, increased liver expression of inflammatory
cytokines, significantly more extended
liver fibrosis, and areas with
DNA breakage after chronic injury compared with wild-type mice. Wild-type mice infused with exogenous human
protein S exhibited exacerbated liver injury and increased number of hepatic stellate cells compared with untreated mice. Human
protein S inhibited apoptosis and increased Akt pathway activation in hepatic stellate cells. The antiapoptotic activity of
protein S may play a role in chronic liver injury and subsequent
liver fibrosis.